The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

NCT00206557 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Alfred

Collaborators